<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medlit</journal-id><journal-title-group><journal-title xml:lang="ru">Гигиена и санитария</journal-title><trans-title-group xml:lang="en"><trans-title>Hygiene and Sanitation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0016-9900</issn><issn pub-type="epub">2412-0650</issn><publisher><publisher-name>Federal Scientific Center of Hygiene named after F.F. Erisman</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47470/0016-9900-2023-102-5-502-508</article-id><article-id custom-type="edn" pub-id-type="custom">zhlqrj</article-id><article-id custom-type="elpub" pub-id-type="custom">medlit-3122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОФИЛАКТИЧЕСКАЯ ТОКСИКОЛОГИЯ И ГИГИЕНИЧЕСКОЕ НОРМИРОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PREVENTIVE TOXICOLOGY AND HYGIENIC STANDARTIZATION</subject></subj-group></article-categories><title-group><article-title>Особенности токсического действия нано- и микрочастицоксида алюминия при многократной ингаляционной экспозиции</article-title><trans-title-group xml:lang="en"><trans-title>Peculiarities of toxic effects produced by aluminum oxide nano- and microparticles under multiple inhalation exposure</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Землянова</surname><given-names>Марина Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Zemlyanova</surname><given-names>Marina A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор мед. наук, профессор, зав. отд. биохимических и цитогенетических методов диагностики ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения», 614045, Пермь.</p><p>e-mail: zem@fcrisk.ru</p></bio><bio xml:lang="en"><p>MD, PhD, DSci, Professor, Head of the Department of Biochemical and Сytogenetic Diagnostics of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, Perm, 614045, Russian Federation.</p><p>e-mail: zem@fcrisk.ru</p></bio><email xlink:type="simple">zem@fcrisk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зайцева</surname><given-names>Нина В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zaitseva</surname><given-names>Nina V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Степанков</surname><given-names>Марк С.</given-names></name><name name-style="western" xml:lang="en"><surname>Stepankov</surname><given-names>Mark S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека; ФГБОУ ВО «Пермский государственный национальный исследовательский университет»; ФГБОУ ВО «Пермский национальный исследовательский политехнический университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific Center for Medical and Preventive Health Risk Management Technologies; Perm State National Research University; Perm National Research Polytechnic University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека; ФГБУ «Российская академия наук»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific Center for Medical and Preventive Health Risk Management Technologies; Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Scientific Center for Medical and Preventive Health Risk Management Technologies</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>23</day><month>06</month><year>2023</year></pub-date><volume>102</volume><issue>5</issue><fpage>502</fpage><lpage>508</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Землянова М.А., Зайцева Н.В., Степанков М.С., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Землянова М.А., Зайцева Н.В., Степанков М.С.</copyright-holder><copyright-holder xml:lang="en">Zemlyanova M.A., Zaitseva N.V., Stepankov M.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rjhas.ru/jour/article/view/3122">https://www.rjhas.ru/jour/article/view/3122</self-uri><abstract><sec><title>Введение</title><p>Введение. Наночастицы оксида алюминия (НЧ Al2O3) имеют широкое практическое применение в сфере нанотехнологий, связанных с химической, пищевой, медицинской парфюмерно-косметической отраслями промышленности. В условиях развития наноиндустрии использование НЧ Al2O3 может обусловливать загрязнение атмосферного воздуха, формирующее риски для здоровья населения в условиях длительной аэрогенной экспозиции. Детальное исследование патогенетических особенностей токсического действия НЧ Al2O3 и сравнительный анализ с микроразмерным химическим аналогом при ингаляционной экспозиции направлены на повышение эффективности мер профилактики.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Исследованы физические свойства нано- и микрочастиц Al2O3. В эксперименте на крысах линии Wistar выполнен сравнительный анализ и дана характеристика патогенетических особенностей токсического действия частиц при многократной ингаляционной экспозиции.</p></sec><sec><title>Результаты</title><p>Результаты. По параметрам размера, формы, площади поверхности и суммарного объёма пор изучаемый образец является наноматериалом, существенно отличающимся от микроразмерного аналога. Воздействие НЧ Al2O3 по сравнению с микрочастицами (МЧ) вызывает более выраженные изменения поведенческих реакций крыс. При экспозиции НЧ Al2O3 установлено статистически значимое увеличение концентрации алюминия относительно контроля в 1,62–55,2 раза в лёгких, печени, головном мозге и крови. При этом концентрация изучаемого элемента в данных органах выше в 1,55–7,65 раза в сравнении с МЧ. Экспозиция НЧ Al2O3 вызывает изменение биохимических показателей относительно контроля (повышение активности АЛТ, АСТ, ЩФ, ЛДГ, концентрации билирубина прямого, ГАМК, глутаминовой кислоты, МДА) и группы сравнения (АЛТ, АСТ, ЩФ, ГАМК, МДА, глутаминовая кислота). При воздействии НЧ Al2O3 патоморфологические изменения установлены в тканях лёгких, головного мозга, сердца и печени, тогда как при воздействии микрочастиц — только в тканях лёгких. Степень изменений значительнее при экспозиции НЧ, а изменения структуры тканей охватывают большее число органов.</p></sec><sec><title>Ограничения исследования</title><p>Ограничения исследования. Исследование выполнено только при многократной ингаляционной экспозиции НЧ и МЧ Al2O3 на крысах линии Wistar.</p></sec><sec><title>Заключение</title><p>Заключение. НЧ Al2O3 обладают большей степенью токсичности относительно микроразмерного химического аналога, о чём свидетельствуют большее число органов бионакопления, более выраженные патоморфологические и патофункциональные нарушения. Полученные результаты необходимо учитывать при разработке гигиенических рекомендаций, направленных на предупреждение и минимизацию негативных эффектов НЧ Al2O3 на здоровье человека.</p><p>Соблюдение этических стандартов. Исследование выполнено в соответствии с Европейской конвенцией по защите позвоночных животных, используемых для экспериментальных или в иных научных целях (ETS № 123), и требованиями этического комитета ФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения» (протокол № 5 от 20.01.2021 г.).</p></sec><sec><title>Участие авторов</title><p>Участие авторов: Землянова М.А. — концепция и дизайн исследования, обработка материала, написание текста; Зайцева Н.В. — концепция и дизайн исследования, статистическая обработка материала, редактирование; Степанков М.С. — сбор и обработка материала. Все соавторы — утверждение окончательного варианта статьи, ответственность за целостность всех частей статьи.</p></sec><sec><title>Конфликт интересов</title><p>Конфликт интересов. Авторы декларируют отсутствие явных и потенциальных конфликтов интересов в связи с публикацией данной статьи.</p></sec><sec><title>Финансирование</title><p>Финансирование. Исследование выполнено за счёт федерального бюджета.</p></sec><sec><title>Поступила</title><p>Поступила: 31.03.2023 / Принята к печати: 31.05.2023 / Опубликована: 20.06.2023</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Aluminum oxide nanoparticles (Al2O3 NPs) are widely used in nanotechnologies employed in various branches including chemical, food, and medical industry and perfume and cosmetics production. This high demand for Al2O3 NPs, given the wide-scale development of nanoindustries, can, in its turn, lead to ambient air pollution that creates public health risks under long-term exposure to it. Given that, it seems relevant to perform profound investigation with its focus on pathogenetic features of toxic effects produced by these nanoparticles and comparatively analyze them with effects produced by a micro-sized chemical analog under inhalation exposure to introduce more effective prevention.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. We examined chemical properties of Al2O3, nano- and microparticles (MPs) in an experiment on Wistar rats, comparatively analyzed the results and described pathogenetic features of toxic effects produced by the examined particles under multiple inhalation exposure. </p></sec><sec><title>Results</title><p>Results. The examined samples were a nanomaterial judging by such parameters as particle size, shape, surface area, and total pore volume. They differed substantially from their micro-sized analog. Exposure to Al2O3 NPs causes more pronounced changes in the behaviour of rats relative to MPs. Under exposure to Al2O3 NPs, aluminum concentrations were statistically significantly by 1.62–55.2 times higher in the lungs, liver, brain and blood. The concentration of the examined elements was by 1.55–7.65 times higher in these organs as compared to exposure to the micro-sized particles. Exposure to Al2O3 NPs induced changes in biochemical indicators of negative effects against the control (exposure to micro-sized particles). We established higher activity of ALT, AST, AP, LDH, and elevated levels of direct bilirubin, GABA, glutamine acid, and MDA against the same indicators in the control group. Pathomorphological changes were identified in the lungs, brain, heart, and liver under exposure to Al2O3 NPs whereas exposure to the micro-sized analog induced such changes only in the lungs. Exposure to NPs induced more apparent changes in tissue structures in many organs. </p></sec><sec><title>Limitations</title><p>Limitations. The study involved only multiple inhalation exposure to Al2O3 NPs and MPs in an experiment on Wistar rats.</p></sec><sec><title>Conclusion</title><p>Conclusion. Al2O3 NPs are more toxic than their micro-sized chemical analog; this is evidenced by a greater number of organs where bioaccumulation occurs, more apparent pathomorphological changes and pathological functional disorders. The study results should be considered when developing hygienic recommendations aimed at preventing and minimizing negative effects produced by Al2O3 NPs on human health.</p><p>Compliance with ethical standards. The study was accomplished in accordance with the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (ETS No. 123) and requirements of the Local Committee on Ethics of the Federal Scientific Center for Medical and Preventive Health Risk Management Technologies (the Meeting Report No. 5 issued on January 20, 2021).</p></sec><sec><title>Contribution</title><p>Contribution: Zemlyanova М.А. — the study concept and design, data analysis, writing; Zaitseva N.V. — the study concept and design, statistical data analysis, editing; Stepankov М.S. — data collection and analysis. All the authors have approved the final variant of the article and bear full responsibility for its integrity. </p></sec><sec><title>Conflict of interest</title><p>Conflict of interest. The authors declare no conflict of interest.</p></sec><sec><title>Acknowledgement</title><p>Acknowledgement. The research was granted financial support from the federal budget.</p></sec><sec><title>Received</title><p>Received: March 31, 2023 / Accepted: May 31, 2023 / Published: June 20, 2023</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>оксид алюминия</kwd><kwd>наночастицы</kwd><kwd>токсичность</kwd><kwd>патоморфологические изменения</kwd><kwd>бионакопление</kwd><kwd>ингаляционная экспозиция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>aluminum oxide</kwd><kwd>nanoparticles</kwd><kwd>toxicity</kwd><kwd>pathomorphological changes</kwd><kwd>bioaccumulation</kwd><kwd>inhalation exposure</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">GlobeNewswire. Research and Markets. Global nanomaterials market (2021 to 2029) – featuring BASF, Bayer and Chasm Technologies among others. Available at: https://www.globenewswire.com/news-release/2021/05/18/2231307/28124/en/Global-Nanomaterials-Market-2021-to-2029-Featuring-BASF-Bayer-and-Chasm-Technologies-Among-Others.html</mixed-citation><mixed-citation xml:lang="en">GlobeNewswire. Research and Markets. Global nanomaterials market (2021 to 2029) – featuring BASF, Bayer and Chasm Technologies among others. Available at: https://www.globenewswire.com/news-release/2021/05/18/2231307/28124/en/Global-Nanomaterials-Market-2021-to-2029-Featuring-BASF-Bayer-and-Chasm-Technologies-Among-Others.html</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Research and Markets. Nanotechnology market – size, share, COVID impact analysis and forecast to 2027; 2021. Available at: https://www.researchandmarkets.com/reports/5308793/2021-nanotechnology-market-size-share-covid</mixed-citation><mixed-citation xml:lang="en">Research and Markets. Nanotechnology market – size, share, COVID impact analysis and forecast to 2027; 2021. Available at: https://www.researchandmarkets.com/reports/5308793/2021-nanotechnology-market-size-share-covid</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Piracha S., Saleem S. Nanoparticle: role in chemical industries, potential sources and chemical catalysis applications. Sch. Int. J. Chem. Mat. Sci. 2021; 4(4): 40–5. https://doi.org/10.36348/sijcms.2021.v04i04.006</mixed-citation><mixed-citation xml:lang="en">Piracha S., Saleem S. Nanoparticle: role in chemical industries, potential sources and chemical catalysis applications. Sch. Int. J. Chem. Mat. Sci. 2021; 4(4): 40–5. https://doi.org/10.36348/sijcms.2021.v04i04.006</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Shafiq M., Anjum S., Hano C., Anjum I., Abbasi B.H. An overview of the applications of nanomaterials and nanodevices in the food industry. Foods. 2020; 9(2): 148. https://doi.org/10.3390/foods9020148</mixed-citation><mixed-citation xml:lang="en">Shafiq M., Anjum S., Hano C., Anjum I., Abbasi B.H. An overview of the applications of nanomaterials and nanodevices in the food industry. Foods. 2020; 9(2): 148. https://doi.org/10.3390/foods9020148</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Shafique M., Luo X. Nanotechnology in transportation vehicles: an overview of its applications, environmental, health and safety concerns. Materials (Basel). 2019; 12(15): 2493. https://doi.org/10.3390/ma12152493</mixed-citation><mixed-citation xml:lang="en">Shafique M., Luo X. Nanotechnology in transportation vehicles: an overview of its applications, environmental, health and safety concerns. Materials (Basel). 2019; 12(15): 2493. https://doi.org/10.3390/ma12152493</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Salata O. Applications of nanoparticles in biology and medicine. J. Nanobiotechnology. 2004; 2(1): 3. https://doi.org/10.1186/1477-3155-2-3</mixed-citation><mixed-citation xml:lang="en">Salata O. Applications of nanoparticles in biology and medicine. J. Nanobiotechnology. 2004; 2(1): 3. https://doi.org/10.1186/1477-3155-2-3</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Luo L., Ding Y., Xu Y. Amperometric biosensors based on alumina nanoparticles-chitosan-horseradish peroxidase nanobiocomposites for the determination of phenolic compounds. Analyst. 2011; 136(4): 696–701. https://doi.org/10.1039/c0an00752h</mixed-citation><mixed-citation xml:lang="en">Liu X., Luo L., Ding Y., Xu Y. Amperometric biosensors based on alumina nanoparticles-chitosan-horseradish peroxidase nanobiocomposites for the determination of phenolic compounds. Analyst. 2011; 136(4): 696–701. https://doi.org/10.1039/c0an00752h</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Robertson T.A., Sanchez W.Y., Roberts M.S. Are commercially available nanoparticles safe when applied to the skin? J. Biomed. Nanotechnol. 2010; 6(5): 452–68. https://doi.org/10.1166/jbn.2010.1145</mixed-citation><mixed-citation xml:lang="en">Robertson T.A., Sanchez W.Y., Roberts M.S. Are commercially available nanoparticles safe when applied to the skin? J. Biomed. Nanotechnol. 2010; 6(5): 452–68. https://doi.org/10.1166/jbn.2010.1145</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Krewski D., Yokel R.A., Nieboer E., Borchelt D., Cohen J., Harry J., et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J. Toxicol. Environ. Health B. Crit. Rev. 2007; 10(Suppl. 1): 1–269. https://doi.org/10.1080/10937400701597766</mixed-citation><mixed-citation xml:lang="en">Krewski D., Yokel R.A., Nieboer E., Borchelt D., Cohen J., Harry J., et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J. Toxicol. Environ. Health B. Crit. Rev. 2007; 10(Suppl. 1): 1–269. https://doi.org/10.1080/10937400701597766</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Arul Prakash F., Dushendra Babu G.J., Lavanya M. Toxicity studies of aluminium oxide nanoparticles in cell lines. Int. J. Nanotechnol. Appl. 2011; 5(2): 99–107.</mixed-citation><mixed-citation xml:lang="en">Arul Prakash F., Dushendra Babu G.J., Lavanya M. Toxicity studies of aluminium oxide nanoparticles in cell lines. Int. J. Nanotechnol. Appl. 2011; 5(2): 99–107.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bahadar H., Maqbool F., Niaz K., Abdollahi M. Toxicity of nanoparticles and an overview of current experimental models. Iran. Biomed. J. 2016; 20(1): 1–11. https://doi.org/10.7508/ibj.2016.01.001</mixed-citation><mixed-citation xml:lang="en">Bahadar H., Maqbool F., Niaz K., Abdollahi M. Toxicity of nanoparticles and an overview of current experimental models. Iran. Biomed. J. 2016; 20(1): 1–11. https://doi.org/10.7508/ibj.2016.01.001</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chen L., Yokel R.A., Hennig B., Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune Pharmacol. 2008; 3(4): 286–95. https://doi.org/10.1007/s11481-008-9131-5</mixed-citation><mixed-citation xml:lang="en">Chen L., Yokel R.A., Hennig B., Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune Pharmacol. 2008; 3(4): 286–95. https://doi.org/10.1007/s11481-008-9131-5</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">El-Hussainy M.A., Hussein A.M., Abdel-Aziz A., El-Mehasseb I. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can. J. Physiol. Pharmacol. 2016; 94(8): 868–78. https://doi.org/10.1139/cjpp-2015-0446</mixed-citation><mixed-citation xml:lang="en">El-Hussainy M.A., Hussein A.M., Abdel-Aziz A., El-Mehasseb I. Effects of aluminum oxide (Al2O3) nanoparticles on ECG, myocardial inflammatory cytokines, redox state, and connexin 43 and lipid profile in rats: possible cardioprotective effect of gallic acid. Can. J. Physiol. Pharmacol. 2016; 94(8): 868–78. https://doi.org/10.1139/cjpp-2015-0446</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Balasubramanyam A., Sailaja N., Mahboob M., Rahman M.F., Hussain S.M., Grover P. In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. Mutagenesis. 2009; 24(3): 245–51. https://doi.org/10.1093/mutage/gep003</mixed-citation><mixed-citation xml:lang="en">Balasubramanyam A., Sailaja N., Mahboob M., Rahman M.F., Hussain S.M., Grover P. In vivo genotoxicity assessment of aluminium oxide nanomaterials in rat peripheral blood cells using the comet assay and micronucleus test. Mutagenesis. 2009; 24(3): 245–51. https://doi.org/10.1093/mutage/gep003</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol. Sci. 2009; 109(1): 152–67. https://doi.org/10.1093/toxsci/kfp046</mixed-citation><mixed-citation xml:lang="en">Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol. Sci. 2009; 109(1): 152–67. https://doi.org/10.1093/toxsci/kfp046</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Зайцева Н.В., Землянова М.А., Степанков М.С., Игнатова А.М. Оценка токсичности и потенциальной опасности наночастиц оксида алюминия для здоровья человека. Экология человека. 2018; (5): 9–15. https://doi.org/10.33396/1728-0869-2018-5-9-15 https://elibrary.ru/xnzkzv</mixed-citation><mixed-citation xml:lang="en">Zaytseva N.V., Zemlyanova M.A., Stepankov M.S., Ignatova A.M. Scientific forecasting of toxicity and evaluation of hazard potential of aluminum oxide nanoparticles for human health. Ekologiya cheloveka. 2018; (5): 9–15. https://doi.org/10.33396/1728-0869-2018-5-9-15 https://elibrary.ru/xnzkzv (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Грег С., Синг К. Адсорбция, удельная поверхность, пористость. М.: Мир; 1984.</mixed-citation><mixed-citation xml:lang="en">Gregg S., Sing K. Adsorption, Surface Area and Porosity. London: Academic Press Inc.; 1982. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Barrett E.P., Joyner L.G., Halenda P.P. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J. Am. Chem. Soc. 1951; 73: 373–80. https://doi.org/10.1021/ja01145a126</mixed-citation><mixed-citation xml:lang="en">Barrett E.P., Joyner L.G., Halenda P.P. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J. Am. Chem. Soc. 1951; 73: 373–80. https://doi.org/10.1021/ja01145a126</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang N., Xiong G., Liu Z. Toxicity of metal-based nanoparticles: Challenges in the nano era. Front. Bioeng. Biotechnol. 2022; 10: 1001572. https://doi.org/10.3389/fbioe.2022.1001572</mixed-citation><mixed-citation xml:lang="en">Zhang N., Xiong G., Liu Z. Toxicity of metal-based nanoparticles: Challenges in the nano era. Front. Bioeng. Biotechnol. 2022; 10: 1001572. https://doi.org/10.3389/fbioe.2022.1001572</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chen L., Yokel R.A., Hennig B., Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune. Pharmacol. 2008; 3(4): 286–95. https://doi.org/10.1007/s11481-008-9131-5</mixed-citation><mixed-citation xml:lang="en">Chen L., Yokel R.A., Hennig B., Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J. Neuroimmune. Pharmacol. 2008; 3(4): 286–95. https://doi.org/10.1007/s11481-008-9131-5</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Liu H., Zhang W., Fang Y., Yang H., Tian L., Li K., et al. Neurotoxicity of aluminum oxide nanoparticles and their mechanistic role in dopaminergic neuron injury involving p53-related pathways. J. Hazard. Mater. 2020; 392: 122312. https://doi.org/10.1016/j.jhazmat.2020.122312</mixed-citation><mixed-citation xml:lang="en">Liu H., Zhang W., Fang Y., Yang H., Tian L., Li K., et al. Neurotoxicity of aluminum oxide nanoparticles and their mechanistic role in dopaminergic neuron injury involving p53-related pathways. J. Hazard. Mater. 2020; 392: 122312. https://doi.org/10.1016/j.jhazmat.2020.122312</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pham-Huy L.A., He H., Pham-Huy C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008; 4(2): 89–96.</mixed-citation><mixed-citation xml:lang="en">Pham-Huy L.A., He H., Pham-Huy C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008; 4(2): 89–96.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Phaniendra A., Jestadi D.B., Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J. Clin. Biochem. 2015; 30(1): 11–26. https://doi.org/10.1007/s12291-014-0446-0</mixed-citation><mixed-citation xml:lang="en">Phaniendra A., Jestadi D.B., Periyasamy L. Free radicals: properties, sources, targets, and their implication in various diseases. Indian J. Clin. Biochem. 2015; 30(1): 11–26. https://doi.org/10.1007/s12291-014-0446-0</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Arul Prakash F., Dushendra Babu G.J., Lavanya M. Toxicity studies of aluminium oxide nanoparticles in cell lines. Int. J. Nanotechnol. Appl. 2011; 5(2): 99–107.</mixed-citation><mixed-citation xml:lang="en">Arul Prakash F., Dushendra Babu G.J., Lavanya M. Toxicity studies of aluminium oxide nanoparticles in cell lines. Int. J. Nanotechnol. Appl. 2011; 5(2): 99–107.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sirajuddin A., Raparia K., Lewis V.A., Franks T.J., Dhand S., Galvin J.R., et al. Primary Pulmonary Lymphoid Lesions: Radiologic and Pathologic Findings. Radiographics. 2016; 36(1): 53–70. https://doi.org/10.1148/rg.2016140339</mixed-citation><mixed-citation xml:lang="en">Sirajuddin A., Raparia K., Lewis V.A., Franks T.J., Dhand S., Galvin J.R., et al. Primary Pulmonary Lymphoid Lesions: Radiologic and Pathologic Findings. Radiographics. 2016; 36(1): 53–70. https://doi.org/10.1148/rg.2016140339</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kaptein F.H.J., Kroft L.J.M., Hammerschlag G., Ninaber M.K., Bauer M.P., Huisman M.V., et al. Pulmonary infarction in acute pulmonary embolism. Thromb. Res. 2021; 202: 162–9. https://doi.org/10.1016/j.thromres.2021.03.022</mixed-citation><mixed-citation xml:lang="en">Kaptein F.H.J., Kroft L.J.M., Hammerschlag G., Ninaber M.K., Bauer M.P., Huisman M.V., et al. Pulmonary infarction in acute pulmonary embolism. Thromb. Res. 2021; 202: 162–9. https://doi.org/10.1016/j.thromres.2021.03.022</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Mufti F., Amuluru K., Smith B., Damodara N., El-Ghanem M., Singh I.P., et al. Emerging markers of early brain injury and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. World Neurosurg. 2017; 107: 148–59. https://doi.org/10.1016/j.wneu.2017.07.114</mixed-citation><mixed-citation xml:lang="en">Al-Mufti F., Amuluru K., Smith B., Damodara N., El-Ghanem M., Singh I.P., et al. Emerging markers of early brain injury and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. World Neurosurg. 2017; 107: 148–59. https://doi.org/10.1016/j.wneu.2017.07.114</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Suarez J.I., Tarr R.W., Selman W.R. Aneurysmal subarachnoid hemorrhage. N. Engl. J. Med. 2006; 354(4): 387–96. https://doi.org/10.1056/nejmra052732</mixed-citation><mixed-citation xml:lang="en">Suarez J.I., Tarr R.W., Selman W.R. Aneurysmal subarachnoid hemorrhage. N. Engl. J. Med. 2006; 354(4): 387–96. https://doi.org/10.1056/nejmra052732</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Sehba F.A., Hou J., Pluta R.M., Zhang J.H. The importance of early brain injury after subarachnoid hemorrhage. Prog. Neurobiol. 2012; 97(1): 14–37. https://doi.org/10.1016/j.pneurobio.2012.02.003</mixed-citation><mixed-citation xml:lang="en">Sehba F.A., Hou J., Pluta R.M., Zhang J.H. The importance of early brain injury after subarachnoid hemorrhage. Prog. Neurobiol. 2012; 97(1): 14–37. https://doi.org/10.1016/j.pneurobio.2012.02.003</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Fujii M., Yan J., Rolland W.B., Soejima Y., Caner B., Zhang J.H. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl. Stroke Res. 2013; 4(4): 432–46. https://doi.org/10.1007/s12975-013-0257-2</mixed-citation><mixed-citation xml:lang="en">Fujii M., Yan J., Rolland W.B., Soejima Y., Caner B., Zhang J.H. Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl. Stroke Res. 2013; 4(4): 432–46. https://doi.org/10.1007/s12975-013-0257-2</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ciurea A.V., Palade C., Voinescu D., Nica D.A. Subarachnoid hemorrhage and cerebral vasospasm – literature review. J. Med. Life. 2013; 6(2): 120–5.</mixed-citation><mixed-citation xml:lang="en">Ciurea A.V., Palade C., Voinescu D., Nica D.A. Subarachnoid hemorrhage and cerebral vasospasm – literature review. J. Med. Life. 2013; 6(2): 120–5.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Claassen J., Bernardini G.L., Kreiter K., Bates J., Du Y.E., Copeland D., et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001; 32(9): 2012–20. https://doi.org/10.1161/hs0901.095677</mixed-citation><mixed-citation xml:lang="en">Claassen J., Bernardini G.L., Kreiter K., Bates J., Du Y.E., Copeland D., et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001; 32(9): 2012–20. https://doi.org/10.1161/hs0901.095677</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Tang W.K., Wang L., Tsoi K.K.F., Barrash J., Kim J.S. Personality changes after subarachnoid hemorrhage: A systematic review and meta-analysis. J. Psychosom. Res. 2022; 156: 110762. https://doi.org/10.1016/j.jpsychores.2022.110762</mixed-citation><mixed-citation xml:lang="en">Tang W.K., Wang L., Tsoi K.K.F., Barrash J., Kim J.S. Personality changes after subarachnoid hemorrhage: A systematic review and meta-analysis. J. Psychosom. Res. 2022; 156: 110762. https://doi.org/10.1016/j.jpsychores.2022.110762</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Tang W.K., Wang L., Kwok Chu Wong G., Ungvari G.S., Yasuno F., Tsoi K.K.F., et al. Depression after subarachnoid hemorrhage: a systematic review. J. Stroke. 2020; 22(1): 11–28. https://doi.org/10.5853/jos.2019.02103</mixed-citation><mixed-citation xml:lang="en">Tang W.K., Wang L., Kwok Chu Wong G., Ungvari G.S., Yasuno F., Tsoi K.K.F., et al. Depression after subarachnoid hemorrhage: a systematic review. J. Stroke. 2020; 22(1): 11–28. https://doi.org/10.5853/jos.2019.02103</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">M’rad I., Jeljeli M., Rihane N., Hilber P., Sakly M., Amara S. Aluminium oxide nanoparticles compromise spatial learning and memory performance in rats. EXCLI J. 2018; 17: 200–10. https://doi.org/10.17179/excli2017-1050</mixed-citation><mixed-citation xml:lang="en">M’rad I., Jeljeli M., Rihane N., Hilber P., Sakly M., Amara S. Aluminium oxide nanoparticles compromise spatial learning and memory performance in rats. EXCLI J. 2018; 17: 200–10. https://doi.org/10.17179/excli2017-1050</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">M’rad I., Sakly M., Amara S. Aluminum oxide nanoparticles induced cognitive deficits and oxidative stress in frontal cortex and cerebellum of rat. Adv. J. Toxicol. Curr. Res. 2017; 1(1): 7–14.</mixed-citation><mixed-citation xml:lang="en">M’rad I., Sakly M., Amara S. Aluminum oxide nanoparticles induced cognitive deficits and oxidative stress in frontal cortex and cerebellum of rat. Adv. J. Toxicol. Curr. Res. 2017; 1(1): 7–14.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Celis M.E., Torre E. Measurement of grooming behavior. Methods Neurosci. 1993; 14: 359–78.</mixed-citation><mixed-citation xml:lang="en">Celis M.E., Torre E. Measurement of grooming behavior. Methods Neurosci. 1993; 14: 359–78.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Назаренко Г.И., Кишкун А.А. Клиническая оценка результатов лабораторных исследований. М.: Медицина; 2006.</mixed-citation><mixed-citation xml:lang="en">Nazarenko G.I., Kishkun A.A. Clinical Evaluation of Laboratory Results [Klinicheskaya otsenka rezul’tatov laboratornykh issledovaniy]. Moscow: Meditsina; 2006. (in Russian)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
